Quantcast

Latest Atrial septal defect Stories

2010-11-16 19:38:23

American Heart Association Meeting report A less invasive procedure for treating a congenital heart defect in children is a safe alternative to traditional surgery with no five-year difference in risk of death and is associated with a 62 percent reduced risk for neurological events (such as strokes or seizures), according to a study presented at the American Heart Association's Scientific Sessions 2010. In a study of 580 children with secundum atrial septal defect (ASD), researchers evaluated...

2010-11-08 15:52:00

GAINESVILLE, Va., Nov. 8, 2010 /PRNewswire/ -- We are excited to announce that over the next six months Madison Taylor Real Estate will be donating 1/3 of all commissions to the Children's Hospital Foundation. In 2004, we discovered our daughter Madison had a heart defect called Atrial Septal Defect (ASD). We consulted with a local cardiologist who informed us our four-year-old daughter would require open-heart surgery to repair the defect. Thankfully, we sought a second opinion from...

2010-09-14 18:29:23

Provides new insight into the most common form of congenital heart disease Repairing small, seemingly benign holes in a child's heart may be more clinically important than previously thought, as dysfunction could be lurking out of sight. These are the findings from a study conducted by doctors and researchers at Nationwide Children's Hospital and the Ohio State University Medical Center examining a subset of the most common form of congenital heart disease, ventricular septal defect. The...

2010-07-15 16:06:21

Biodegradable implant avoids risks associated with metal devices A novel study by Canadian physicians reported that the BioSTARTM biodegradable implant achieved comparable closure rates to the Amplatzer Septal OccluderTM (ASO) in children with atrial septal defect (ASD). The BioSTAR device displayed successful outcomes, while avoiding issues associated with implants containing substantial amounts of metal. Results of the study, the first to compare the BioSTAR device with the ASO in children,...

2010-06-24 04:00:00

JENA, Germany, June 24, 2010 /PRNewswire/ -- In 2009 the Patents Court of the High Court, Chancery Division, decided that Occlutech's range of Figulla ASD and PFO occluders do not infringe the U.K. part of European Patent 0 808 138. AGA Medical decided to appeal against this decision. The U.K. Court of Appeal (civil division) in London announced its decision confirming that said Figulla ASD and PFO occluders do not infringe said patent. AGA asked for permission to appeal to the...

2010-05-27 13:50:14

Pediatric Heart Network study is largest clinical trial of treatment of patients with congenital heart disease Infants born with a severely underdeveloped heart who undergo a newer surgical procedure are more likely to survive their first year and not require a heart transplant than those who have a more traditional surgical procedure, according to a report by researchers supported by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health....

2009-11-17 12:46:00

NEW YORK, Nov. 17 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. U.S. Market for Cardiac Surgery Devices 2009 http://www.reportlinker.com/p0164136/US-Market-for-Cardiac-Surgery-Devices-2009.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire In 2008, the U.S. market for cardiac surgery devices was valued at over $1.6 billion, representing growth of nearly 7% over 2007. The U.S. Market for Cardiac Surgery...

2009-11-16 07:31:00

MORRISVILLE, N.C., Nov. 16 /PRNewswire/ -- nContact Surgical, Inc. ("nContact"), a leader in the investigation of devices for non-invasive treatment for heart conditions, today announced the initiation of a clinical trial designed to evaluate the safety and efficacy of its Numeris® - AF Tethered Coagulation System with VisiTrax® device in an open-chest concomitant procedure for the treatment of longstanding persistent atrial fibrillation (AF). This...

2009-09-23 10:20:00

JENA, Germany, September 23 /PRNewswire/ -- Occlutech GmbH, the leading European developer of products for septal closure, today announced that the district court of Frankfurt, Germany reversed an earlier court injunction obtained by AGA Medical against Occlutech's sales and marketing activities relating to the newly launched Figulla Flex ranges of ASD and PFO occluders. The district court of Frankfurt reversed its earlier decision that was based on a request by AGA Medical, relying...

2009-09-21 10:54:00

ZURICH, September 21 /PRNewswire/ -- Occlutech AG, the leading European developer of products for septal closure, today announced that, together with its partner in Spain IZASA SA, it defeated a request for an injunction against sales and marketing activities in Spain, launched at the Commercial Court I of Barcelona, Spain by its U.S. competitor AGA Medical. The request by AGA was based on alleged patent infringement and unfair competition claims related to wrongful assumptions and...


Latest Atrial septal defect Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »
Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related